Be a Star
Be a Star this Christmas and help us improve the lives of everyone affected by a brain tumour. Dedicate a star for a loved one who inspires you.Donate a star
This Christmas, donate online and dedicate a virtual star to your loved one.
Make a difference this year and help fund pioneering global research into glioblastomas - the most common and aggressive type of brain tumour. Led by the University of Edinburgh in collaboration with scientists from Canada and Denmark, it has the potential to transform the lives of adults and children affected by a glioblastoma diagnosis by progressing drugs to clinical trials more quickly.
Your online star for your loved one will appear in our sky of hope along with hundreds of others, showing the strength and power of our united community. You can add a short message when dedicating your star, and can return to the online page to view it after donating.
"Our experience has highlighted the vital need for research into this devastating disease. I feel very lucky that I've survived this long with a glioblastoma, but luck shouldn't play a part. A cure is desperately needed."
Oliver was diagnosed in 2012 with a glioblastoma aged just 39.
"My family mean everything to me. When I was diagnosed in 2012 with a glioblastoma, I remember my wife Sharon crying and all I wanted to do was comfort her and tell her it would be OK. It didn't sink in at first, it just didn't seem real.
Family and friends rallied around us with amazing support which was, and continues to be, invaluable because it takes a long time to accept your life has changed forever and to adjust to the 'new' you.
I wanted to maintain a sense of normality so I went back to work as soon as I could, but after 18 months I made the difficult decision to leave because it wiped me out so much that I didn't have the energy to play with my son, Elliot. I had to accept that I couldn't do it all and I made the choice to save my energy for my family – family time has become even more precious since being diagnosed.
The Brain Tumour Charity is funding pioneering, global research into glioblastomas – the most common and aggressive type of brain tumour – giving hope to families just like mine."
In September this year, we began funding new research into glioblastomas. The team, led by Dr Steve Pollard at the University of Edinburgh, includes expert researchers at The Hospital for Sick Kids in Toronto and the University of Copenhagen.
As part of our Quest for Cures initiative, which is driving global collaboration to accelerate advances in brain tumour research, Dr Pollard's team are using technology to look at parcels within cells that contain both DNA and protein to see how they could be linked to causing glioblastomas.
By furthering their understanding of these parcels, the team hope to identify existing drugs that could be used to stop them developing into cancer. This could transform the lives of brain tumour patients.
£50 could help researchers like Dr Pollard discover urgently needed new treatments.
Did you know that less than 2% of funding into cancer research in the UK is spent on brain tumours? Please donate £50, or whatever you can afford, and help us improve the lives of everyone affected by a brain tumour.
Thanks to your generosity last Christmas, our researchers at the University of Cambridge and the University of Edinburgh are making progress in understanding the common signs and symptoms of brain tumours in adults and the potential impact of late diagnosis on clinical care and outcomes. Learn more about how your money is making a difference.
Could purchase the specialist liquid nutrients that are used to grow glioblastoma cells in the lab so researchers can assess responses to different drugs.
Could buy the reaction kits needed to help scientists explore how the DNA in brain tumour cells is different to normal brain cells and explore vital new treatment options.
Could buy specialist equipment to analyse genetic makeup, study protein structure or manipulate cells to behave in different ways.
Could cover a day of research for one of our leading brain tumour researchers to further the understanding of glioblastomas and provide more targeted treatments.